IL45931A - Steroid-binding globulin and process for preparing it - Google Patents
Steroid-binding globulin and process for preparing itInfo
- Publication number
- IL45931A IL45931A IL45931A IL4593174A IL45931A IL 45931 A IL45931 A IL 45931A IL 45931 A IL45931 A IL 45931A IL 4593174 A IL4593174 A IL 4593174A IL 45931 A IL45931 A IL 45931A
- Authority
- IL
- Israel
- Prior art keywords
- steroid
- globulin
- binding
- range
- solution
- Prior art date
Links
- 238000009739 binding Methods 0.000 title claims description 72
- 150000003431 steroids Chemical class 0.000 title claims description 68
- 102000006395 Globulins Human genes 0.000 title claims description 18
- 108010044091 Globulins Proteins 0.000 title claims description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 102000006734 Beta-Globulins Human genes 0.000 claims description 54
- 108010087504 Beta-Globulins Proteins 0.000 claims description 54
- 102000004169 proteins and genes Human genes 0.000 claims description 33
- 108090000623 proteins and genes Proteins 0.000 claims description 33
- 102000005348 Neuraminidase Human genes 0.000 claims description 20
- 108010006232 Neuraminidase Proteins 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- 239000002244 precipitate Substances 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical compound N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 claims description 11
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000011534 incubation Methods 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 239000007858 starting material Substances 0.000 claims description 8
- 239000012535 impurity Substances 0.000 claims description 6
- 210000002826 placenta Anatomy 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 241000607626 Vibrio cholerae Species 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 238000004062 sedimentation Methods 0.000 claims description 5
- 229940118696 vibrio cholerae Drugs 0.000 claims description 5
- 102000004506 Blood Proteins Human genes 0.000 claims description 4
- 108010017384 Blood Proteins Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 229940083575 sodium dodecyl sulfate Drugs 0.000 claims description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 4
- 239000003270 steroid hormone Substances 0.000 claims description 4
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 235000014633 carbohydrates Nutrition 0.000 claims description 3
- 108010074605 gamma-Globulins Proteins 0.000 claims description 3
- 150000002402 hexoses Chemical class 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 238000007693 zone electrophoresis Methods 0.000 claims description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 2
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000002649 immunization Methods 0.000 claims description 2
- 230000003053 immunization Effects 0.000 claims description 2
- 230000000813 microbial effect Effects 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims 3
- 125000000641 acridinyl group Chemical class C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 claims 2
- 239000013060 biological fluid Substances 0.000 claims 2
- 238000002405 diagnostic procedure Methods 0.000 claims 2
- 101710165315 Sialidase A Proteins 0.000 claims 1
- 239000000243 solution Substances 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
- 239000000872 buffer Substances 0.000 description 14
- 239000011780 sodium chloride Substances 0.000 description 10
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 8
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 8
- 235000011130 ammonium sulphate Nutrition 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 7
- 238000010828 elution Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229920005654 Sephadex Polymers 0.000 description 4
- 239000012507 Sephadex™ Substances 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 4
- 229960004756 ethanol Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001251 acridines Chemical class 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 229960002319 barbital Drugs 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- -1 diaminoethyl Chemical group 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- YGFYLMXVAXWONI-UHFFFAOYSA-N 1-ethoxyacridine-2,3-diamine;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.C1=CC=C2C=C3C(OCC)=C(N)C(N)=CC3=NC2=C1 YGFYLMXVAXWONI-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- UMKFSNMRYODECV-UHFFFAOYSA-N 3,3-diamino-3-(2-ethoxyacridin-1-yl)-2-hydroxypropanoic acid Chemical compound CCOC1=C(C2=CC3=CC=CC=C3N=C2C=C1)C(C(C(=O)O)O)(N)N UMKFSNMRYODECV-UHFFFAOYSA-N 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102100021809 Chorionic somatomammotropin hormone 1 Human genes 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 229920006385 Geon Polymers 0.000 description 1
- 101000895818 Homo sapiens Chorionic somatomammotropin hormone 1 Proteins 0.000 description 1
- 101000956228 Homo sapiens Chorionic somatomammotropin hormone 2 Proteins 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 238000012511 carbohydrate analysis Methods 0.000 description 1
- 229940077731 carbohydrate nutrients Drugs 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- YUPQOCKHBKYZMN-UHFFFAOYSA-N ethylaminomethanetriol Chemical compound CCNC(O)(O)O YUPQOCKHBKYZMN-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000012817 gel-diffusion technique Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000007974 sodium acetate buffer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4717—Plasma globulins, lactoglobulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/909—Vibrio
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/814—Pregnancy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos
- Y10S530/851—Placenta; amniotic fluid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2353973A DE2353973C3 (de) | 1973-10-27 | 1973-10-27 | Steroid-bindendes Globulin und Verfahren zu dessen Herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL45931A0 IL45931A0 (en) | 1974-12-31 |
| IL45931A true IL45931A (en) | 1977-08-31 |
Family
ID=5896636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL45931A IL45931A (en) | 1973-10-27 | 1974-10-24 | Steroid-binding globulin and process for preparing it |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4018885A (nl) |
| JP (1) | JPS58404B2 (nl) |
| AT (1) | AT336783B (nl) |
| BE (1) | BE821534A (nl) |
| DE (1) | DE2353973C3 (nl) |
| DK (1) | DK139627C (nl) |
| FR (1) | FR2249093B1 (nl) |
| GB (1) | GB1459617A (nl) |
| IE (1) | IE40191B1 (nl) |
| IL (1) | IL45931A (nl) |
| IT (1) | IT1034074B (nl) |
| LU (1) | LU71184A1 (nl) |
| NL (1) | NL7413812A (nl) |
| NO (1) | NO142961C (nl) |
| SE (1) | SE420412B (nl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1064396A (en) * | 1975-02-18 | 1979-10-16 | Myer L. Coval | Fractional precipitation of gamma globulin with polyethylene glycol |
| US4165370A (en) * | 1976-05-21 | 1979-08-21 | Coval M L | Injectable gamma globulin |
| DE2640387C3 (de) * | 1976-09-08 | 1981-01-22 | Behringwerke Ag, 3550 Marburg | Gewebespezifisches Protein und Verfahren zu dessen Herstellung |
| DE2718326A1 (de) * | 1977-04-25 | 1978-10-26 | Behringwerke Ag | Neues protein und verfahren zu dessen herstellung |
| US4230684A (en) * | 1978-03-16 | 1980-10-28 | Cornell Research Foundation, Inc. | Method for determining steroids in human body liquids |
| DE3013724A1 (de) * | 1980-04-10 | 1981-10-15 | Behringwerke Ag, 3550 Marburg | Neues protein pp (pfeil abwaerts)9(pfeil abwaerts), verfahren zu seiner anreicherung und gewinnung sowieseine verwendung |
| KR0123107B1 (ko) * | 1992-02-27 | 1997-11-12 | 아끼야마 요시히사 | 연소배기가스중의 2산화탄소의 제거방법 |
-
1973
- 1973-10-27 DE DE2353973A patent/DE2353973C3/de not_active Expired
-
1974
- 1974-10-22 NL NL7413812A patent/NL7413812A/nl not_active Application Discontinuation
- 1974-10-24 GB GB4607074A patent/GB1459617A/en not_active Expired
- 1974-10-24 US US05/517,764 patent/US4018885A/en not_active Expired - Lifetime
- 1974-10-24 IL IL45931A patent/IL45931A/en unknown
- 1974-10-25 SE SE7413467A patent/SE420412B/xx unknown
- 1974-10-25 NO NO743852A patent/NO142961C/no unknown
- 1974-10-25 AT AT861274A patent/AT336783B/de active
- 1974-10-25 LU LU71184A patent/LU71184A1/xx unknown
- 1974-10-25 IE IE2202/74A patent/IE40191B1/xx unknown
- 1974-10-25 IT IT28819/74A patent/IT1034074B/it active
- 1974-10-25 DK DK560474A patent/DK139627C/da active
- 1974-10-26 JP JP49123046A patent/JPS58404B2/ja not_active Expired
- 1974-10-28 FR FR7435940A patent/FR2249093B1/fr not_active Expired
- 1974-10-28 BE BE149923A patent/BE821534A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO142961C (no) | 1980-11-19 |
| FR2249093A1 (nl) | 1975-05-23 |
| IL45931A0 (en) | 1974-12-31 |
| IE40191B1 (en) | 1979-03-28 |
| DK139627B (da) | 1979-03-19 |
| DK560474A (nl) | 1975-06-23 |
| FR2249093B1 (nl) | 1978-06-16 |
| IE40191L (en) | 1975-04-27 |
| ATA861274A (de) | 1976-09-15 |
| JPS5071819A (nl) | 1975-06-14 |
| JPS58404B2 (ja) | 1983-01-06 |
| DE2353973B2 (de) | 1979-02-15 |
| IT1034074B (it) | 1979-09-10 |
| LU71184A1 (nl) | 1976-08-19 |
| NL7413812A (nl) | 1975-04-29 |
| SE420412B (sv) | 1981-10-05 |
| DE2353973A1 (de) | 1975-05-07 |
| BE821534A (fr) | 1975-04-28 |
| GB1459617A (en) | 1976-12-22 |
| US4018885A (en) | 1977-04-19 |
| NO743852L (nl) | 1975-05-26 |
| DK139627C (da) | 1979-10-29 |
| AT336783B (de) | 1977-05-25 |
| NO142961B (no) | 1980-08-11 |
| DE2353973C3 (de) | 1979-10-04 |
| SE7413467L (nl) | 1975-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4217339A (en) | Glycoprotein and process for isolating it | |
| US4191533A (en) | Pregnancy-specific β1 -glycoprotein and process for isolating it | |
| Tishkoff et al. | Preparation of Highly Purified Prothrombin Complex: I. CRYSTALIZATION, BIOLOGICAL ACTIVITY, AND MOLECULAR PROPERTIES | |
| US4269825A (en) | New glycoprotein and process for isolating it | |
| CA1186993A (en) | Protein (pp in16 xx), a process for concentrating and isolating it, and its use | |
| US4301064A (en) | Ubiquitary tissue protein PP8 | |
| US4254021A (en) | Tissue specific protein and process for preparing same | |
| US4302385A (en) | Placenta-specific tissue protein PP10 | |
| US4468345A (en) | Protein (PP17), a process for concentrating and isolating it and its use | |
| US4500451A (en) | New protein PP13 extracted from human placental tissues and use thereof | |
| US4746731A (en) | Isolated tissue protein PP18 | |
| US4018885A (en) | Steroid-binding globulin and process for preparing it and antibodies thereto | |
| JPH0132840B2 (nl) | ||
| US4368148A (en) | Protein PP9, process for its enrichment and its isolation and its use | |
| Horstmann et al. | Isolation of rabbit C3, Factor B, and Factor H and comparison of their properties with those of the human analog. | |
| US4065445A (en) | Pregnancy-specific β1 -glycoprotein and process for isolating it | |
| US4592863A (en) | Protein PP20, a process for obtaining it, and its use | |
| US4325866A (en) | Protein, PP11, a process for its preparation and its use | |
| US4297274A (en) | Protein from red blood cells and process for isolating it | |
| US4309339A (en) | Leucine-rich 3,1-S-α2 -glycoprotein, process for isolating it and its use | |
| US4594328A (en) | Tissue protein PP21, a process for obtaining it and its use | |
| AT349649B (de) | Gewinnung von antiseren | |
| Bohn et al. | Placenta-specific tissue protein PP 10 | |
| Bohn et al. | Ubiquitary tissue protein PP 8 |